U.S. regulators have approved the first cervical cancer testing kit that allows women to collect their own sample at home before shipping it to a laboratory, according to a medical device company.

This is an audio transcript of the FT News Briefing podcast episode: ‘Swamp Notes — Trump takes on higher ed’ ...